medroxyprogesterone acetate has been researched along with Urinary Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cancelo, MJ; Castelo-Branco, C; Palacios, S; Vázquez, F | 1 |
| Fushiki, H | 1 |
1 review(s) available for medroxyprogesterone acetate and Urinary Tract Diseases
| Article | Year |
|---|---|
[Ovarian remnant syndrome].
Topics: Diagnosis, Differential; Digestive System Diseases; Female; Humans; Medroxyprogesterone Acetate; Ovarian Diseases; Ovarian Neoplasms; Ovariectomy; Pelvic Pain; Prognosis; Radiotherapy; Syndrome; Urogenital Surgical Procedures; Urologic Diseases | 2006 |
1 trial(s) available for medroxyprogesterone acetate and Urinary Tract Diseases
| Article | Year |
|---|---|
Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.
Topics: Administration, Cutaneous; Administration, Intravaginal; Adult; Atrophy; Colposcopy; Contraceptive Agents, Female; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrogen Replacement Therapy; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Papanicolaou Test; Postmenopause; Treatment Outcome; Urologic Diseases; Vagina; Vaginal Creams, Foams, and Jellies; Vaginal Diseases; Vaginal Smears | 2005 |